Report - Research. · 10/16/2014  · 4 ABSTRACT Purpose: This Phase I trial evaluated the safety, pharmacokinetics, pharmacodynamics and of demcizumab (OMP-21M18), a humanized IgG2 monoclonal

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form